Regenesis Biomedical

Category: Medical Devices & Equipment

Regenesis Biomedical Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant® Therapy System, indicated for the palliative treatment of post-operative pain and edema in superficial soft tissue.

Our customers include health care facilities and providers that serve patients being treated by acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.

The Provant Therapy System is a medical device that aids in the reduction of pain and swelling of the skin and soft tissues following surgery.

Provant is low-risk, noninvasive and painless. Training and therapy are easy for health care providers and patients, requiring no changes to existing treatment protocols. Provant is available upon prescription from a licensed healthcare provider.
Treatment is twice daily for 30-minutes, and is administered simply by placing the Provant treatment applicator adjacent to the surgical site and activating the automatically dosed and timed system.

The Provant Therapy System is compact, lightweight and portable. The system consists of circuitry, a power source, treatment applicator, and wall plug in a durable plastic case.
The Provant Therapy System has numerous advantages that, taken together, set it apart from the competition.